APO Research
Talk to an analyst

APO RESEARCH · REPORT

Semi-Solid Dosage Form

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Semi-Solid Dosage Form Industry Growth and Trends Forecast to 2032

29 December 2025124 pages

Choose your research edition.

Industry ResearchSemi-Solid Dosage Form Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Semi-Solid Dosage Form Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Semi-Solid Dosage Form Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Semi-Solid Dosage Form Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Semi-Solid Dosage Form Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Semi-Solid Dosage Form market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Semi-Solid Dosage Form is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Semi-Solid Dosage Form is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Semi-Solid Dosage Form is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Semi-Solid Dosage Form include Aclaris Therapeutics, Inc., Akorn Inc. (US), Allergan plc, Almirall, S.A, Bausch Health Companies, Biofrontera, Inc., Cipla Ltd, Crescita Therapeutics Inc. and Crown Laboratories Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Semi-Solid Dosage Form market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Semi-Solid Dosage Form market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Semi-Solid Dosage Form market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Semi-Solid Dosage Form.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Semi-Solid Dosage Form market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Semi-Solid Dosage Form Market by Company

Aclaris Therapeutics, Inc.

Akorn Inc. (US)

Allergan plc

Almirall, S.A

Bausch Health Companies

Biofrontera, Inc.

Cipla Ltd

Crescita Therapeutics Inc.

Crown Laboratories Inc.

Encore Dermatology, Inc.

Glenmark Pharmaceuticals

Hisamitsu Pharmaceutical

Ingenus Pharmaceuticals

LEO Pharma

Mylan N.V.

Novartis AG

Perrigo Pharma

Taro Pharmaceutical Industries Ltd.

Teligent Pharma

Bayer AG

GlaxoSmithKline plc

Merck & Co

Johnson & Johnson

Nestlé SA

Sun Pharmaceuticals

Semi-Solid Dosage Form Segment by Type

Ointments

Gels

Others

Semi-Solid Dosage Form Segment by Application

Nasal Cavity

Skin

Vaginal Cavity

Rectal Cavity

Others

Semi-Solid Dosage Form Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Semi-Solid Dosage Form market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Semi-Solid Dosage Form and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Semi-Solid Dosage Form.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Semi-Solid Dosage Form manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Semi-Solid Dosage Form in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ointments Table 2. Major Company of Gels Table 3. Major Company of Others Table 4. Global Semi-Solid Dosage Form Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Semi-Solid Dosage Form Sales by Type (2021-2026) & (K Units) Table 6. Global Semi-Solid Dosage Form Sales Market Share in Volume by Type (2021-2026) Table 7. Global Semi-Solid Dosage Form Sales by Type (2021-2026) & (US$ Million) Table 8. Global Semi-Solid Dosage Form Sales Market Share in Value by Type (2021-2026) Table 9. Global Semi-Solid Dosage Form Price by Type (2021-2026) & (US$/Unit) Table 10. Global Semi-Solid Dosage Form Sales by Type (2027-2032) & (K Units) Table 11. Global Semi-Solid Dosage Form Sales Market Share in Volume by Type (2027-2032) Table 12. Global Semi-Solid Dosage Form Sales by Type (2027-2032) & (US$ Million) Table 13. Global Semi-Solid Dosage Form Sales Market Share in Value by Type (2027-2032) Table 14. Global Semi-Solid Dosage Form Price by Type (2027-2032) & (US$/Unit) Table 15. North America Semi-Solid Dosage Form Sales by Type (2021-2026) & (K Units) Table 16. North America Semi-Solid Dosage Form Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Semi-Solid Dosage Form Sales by Type (2021-2026) & (K Units) Table 18. Europe Semi-Solid Dosage Form Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Semi-Solid Dosage Form Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Semi-Solid Dosage Form Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Semi-Solid Dosage Form Sales by Type (2021-2026) & (K Units) Table 22. Latin America Semi-Solid Dosage Form Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Semi-Solid Dosage Form Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Semi-Solid Dosage Form Sales by Type (2021-2026) & (US$ Million) Table 25. Semi-Solid Dosage Form Industry Trends Table 26. Semi-Solid Dosage Form Industry Drivers Table 27. Semi-Solid Dosage Form Industry Opportunities and Challenges Table 28. Semi-Solid Dosage Form Industry Restraints Table 29. Global Semi-Solid Dosage Form Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Semi-Solid Dosage Form Revenue Market Share by Company (2021-2026) Table 31. Global Semi-Solid Dosage Form Sales by Company (2021-2026) & (K Units) Table 32. Global Semi-Solid Dosage Form Sales Share by Company (2021-2026) Table 33. Global Semi-Solid Dosage Form Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Semi-Solid Dosage Form Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Semi-Solid Dosage Form Major Company Production Sites and Headquarters Table 36. Global Semi-Solid Dosage Form Company, Product Type & Application Table 37. Global Semi-Solid Dosage Form Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Semi-Solid Dosage Form by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Semi-Solid Dosage Form Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Semi-Solid Dosage Form Sales by Region (2021-2026) & (K Units) Table 42. Global Semi-Solid Dosage Form Sales Market Share in Volume by Region (2021-2026) Table 43. Global Semi-Solid Dosage Form Sales by Region (2021-2026) & (US$ Million) Table 44. Global Semi-Solid Dosage Form Sales Market Share in Value by Region (2021-2026) Table 45. Global Semi-Solid Dosage Form Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Semi-Solid Dosage Form Sales by Region (2027-2032) & (K Units) Table 47. Global Semi-Solid Dosage Form Sales Market Share in Volume by Region (2027-2032) Table 48. Global Semi-Solid Dosage Form Sales by Region (2027-2032) & (US$ Million) Table 49. Global Semi-Solid Dosage Form Sales Market Share in Value by Region (2027-2032) Table 50. Global Semi-Solid Dosage Form Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Semi-Solid Dosage Form Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Semi-Solid Dosage Form Sales by Application (2021-2026) & (K Units) Table 53. Global Semi-Solid Dosage Form Sales Market Share in Volume by Application (2021-2026) Table 54. Global Semi-Solid Dosage Form Sales by Application (2021-2026) & (US$ Million) Table 55. Global Semi-Solid Dosage Form Sales Market Share in Value by Application (2021-2026) Table 56. Global Semi-Solid Dosage Form Price by Application (2021-2026) & (US$/Unit) Table 57. Global Semi-Solid Dosage Form Sales by Application (2027-2032) & (K Units) Table 58. Global Semi-Solid Dosage Form Sales Market Share in Volume by Application (2027-2032) Table 59. Global Semi-Solid Dosage Form Sales by Application (2027-2032) & (US$ Million) Table 60. Global Semi-Solid Dosage Form Sales Market Share in Value by Application (2027-2032) Table 61. Global Semi-Solid Dosage Form Price by Application (2027-2032) & (US$/Unit) Table 62. North America Semi-Solid Dosage Form Sales by Application (2021-2026) & (K Units) Table 63. North America Semi-Solid Dosage Form Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Semi-Solid Dosage Form Sales by Application (2021-2026) & (K Units) Table 65. Europe Semi-Solid Dosage Form Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Semi-Solid Dosage Form Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Semi-Solid Dosage Form Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Semi-Solid Dosage Form Sales by Application (2021-2026) & (K Units) Table 69. Latin America Semi-Solid Dosage Form Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Semi-Solid Dosage Form Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Semi-Solid Dosage Form Sales by Application (2021-2026) & (US$ Million) Table 72. Aclaris Therapeutics, Inc. Company Information Table 73. Aclaris Therapeutics, Inc. Business Overview Table 74. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product Portfolio Table 76. Aclaris Therapeutics, Inc. Recent Development Table 77. Akorn Inc. (US) Company Information Table 78. Akorn Inc. (US) Business Overview Table 79. Akorn Inc. (US) Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Akorn Inc. (US) Semi-Solid Dosage Form Product Portfolio Table 81. Akorn Inc. (US) Recent Development Table 82. Allergan plc Company Information Table 83. Allergan plc Business Overview Table 84. Allergan plc Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Allergan plc Semi-Solid Dosage Form Product Portfolio Table 86. Allergan plc Recent Development Table 87. Almirall, S.A Company Information Table 88. Almirall, S.A Business Overview Table 89. Almirall, S.A Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Almirall, S.A Semi-Solid Dosage Form Product Portfolio Table 91. Almirall, S.A Recent Development Table 92. Bausch Health Companies Company Information Table 93. Bausch Health Companies Business Overview Table 94. Bausch Health Companies Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Bausch Health Companies Semi-Solid Dosage Form Product Portfolio Table 96. Bausch Health Companies Recent Development Table 97. Biofrontera, Inc. Company Information Table 98. Biofrontera, Inc. Business Overview Table 99. Biofrontera, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Biofrontera, Inc. Semi-Solid Dosage Form Product Portfolio Table 101. Biofrontera, Inc. Recent Development Table 102. Cipla Ltd Company Information Table 103. Cipla Ltd Business Overview Table 104. Cipla Ltd Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Cipla Ltd Semi-Solid Dosage Form Product Portfolio Table 106. Cipla Ltd Recent Development Table 107. Crescita Therapeutics Inc. Company Information Table 108. Crescita Therapeutics Inc. Business Overview Table 109. Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Crescita Therapeutics Inc. Semi-Solid Dosage Form Product Portfolio Table 111. Crescita Therapeutics Inc. Recent Development Table 112. Crown Laboratories Inc. Company Information Table 113. Crown Laboratories Inc. Business Overview Table 114. Crown Laboratories Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Crown Laboratories Inc. Semi-Solid Dosage Form Product Portfolio Table 116. Crown Laboratories Inc. Recent Development Table 117. Encore Dermatology, Inc. Company Information Table 118. Encore Dermatology, Inc. Business Overview Table 119. Encore Dermatology, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Encore Dermatology, Inc. Semi-Solid Dosage Form Product Portfolio Table 121. Encore Dermatology, Inc. Recent Development Table 122. Glenmark Pharmaceuticals Company Information Table 123. Glenmark Pharmaceuticals Business Overview Table 124. Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Glenmark Pharmaceuticals Semi-Solid Dosage Form Product Portfolio Table 126. Glenmark Pharmaceuticals Recent Development Table 127. Hisamitsu Pharmaceutical Company Information Table 128. Hisamitsu Pharmaceutical Business Overview Table 129. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product Portfolio Table 131. Hisamitsu Pharmaceutical Recent Development Table 132. Ingenus Pharmaceuticals Company Information Table 133. Ingenus Pharmaceuticals Business Overview Table 134. Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Ingenus Pharmaceuticals Semi-Solid Dosage Form Product Portfolio Table 136. Ingenus Pharmaceuticals Recent Development Table 137. LEO Pharma Company Information Table 138. LEO Pharma Business Overview Table 139. LEO Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. LEO Pharma Semi-Solid Dosage Form Product Portfolio Table 141. LEO Pharma Recent Development Table 142. Mylan N.V. Company Information Table 143. Mylan N.V. Business Overview Table 144. Mylan N.V. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Mylan N.V. Semi-Solid Dosage Form Product Portfolio Table 146. Mylan N.V. Recent Development Table 147. Novartis AG Company Information Table 148. Novartis AG Business Overview Table 149. Novartis AG Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Novartis AG Semi-Solid Dosage Form Product Portfolio Table 151. Novartis AG Recent Development Table 152. Perrigo Pharma Company Information Table 153. Perrigo Pharma Business Overview Table 154. Perrigo Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Perrigo Pharma Semi-Solid Dosage Form Product Portfolio Table 156. Perrigo Pharma Recent Development Table 157. Taro Pharmaceutical Industries Ltd. Company Information Table 158. Taro Pharmaceutical Industries Ltd. Business Overview Table 159. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product Portfolio Table 161. Taro Pharmaceutical Industries Ltd. Recent Development Table 162. Teligent Pharma Company Information Table 163. Teligent Pharma Business Overview Table 164. Teligent Pharma Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Teligent Pharma Semi-Solid Dosage Form Product Portfolio Table 166. Teligent Pharma Recent Development Table 167. Bayer AG Company Information Table 168. Bayer AG Business Overview Table 169. Bayer AG Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Bayer AG Semi-Solid Dosage Form Product Portfolio Table 171. Bayer AG Recent Development Table 172. GlaxoSmithKline plc Company Information Table 173. GlaxoSmithKline plc Business Overview Table 174. GlaxoSmithKline plc Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. GlaxoSmithKline plc Semi-Solid Dosage Form Product Portfolio Table 176. GlaxoSmithKline plc Recent Development Table 177. Merck & Co Company Information Table 178. Merck & Co Business Overview Table 179. Merck & Co Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Merck & Co Semi-Solid Dosage Form Product Portfolio Table 181. Merck & Co Recent Development Table 182. Johnson & Johnson Company Information Table 183. Johnson & Johnson Business Overview Table 184. Johnson & Johnson Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Johnson & Johnson Semi-Solid Dosage Form Product Portfolio Table 186. Johnson & Johnson Recent Development Table 187. Nestlé SA Company Information Table 188. Nestlé SA Business Overview Table 189. Nestlé SA Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Nestlé SA Semi-Solid Dosage Form Product Portfolio Table 191. Nestlé SA Recent Development Table 192. Sun Pharmaceuticals Company Information Table 193. Sun Pharmaceuticals Business Overview Table 194. Sun Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Sun Pharmaceuticals Semi-Solid Dosage Form Product Portfolio Table 196. Sun Pharmaceuticals Recent Development Table 197. North America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. North America Semi-Solid Dosage Form Sales by Country (2021-2026) & (K Units) Table 199. North America Semi-Solid Dosage Form Sales Market Share by Country (2021-2026) Table 200. North America Semi-Solid Dosage Form Sales Forecast by Country (2027-2032) & (K Units) Table 201. North America Semi-Solid Dosage Form Sales Market Share Forecast by Country (2027-2032) Table 202. North America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. North America Semi-Solid Dosage Form Market Size by Country (2021-2026) & (US$ Million) Table 204. North America Semi-Solid Dosage Form Market Share by Country (2021-2026) Table 205. North America Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. North America Semi-Solid Dosage Form Market Share Forecast by Country (2027-2032) Table 207. Europe Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 208. Europe Semi-Solid Dosage Form Sales by Country (2021-2026) & (K Units) Table 209. Europe Semi-Solid Dosage Form Sales Market Share by Country (2021-2026) Table 210. Europe Semi-Solid Dosage Form Sales Forecast by Country (2027-2032) & (K Units) Table 211. Europe Semi-Solid Dosage Form Sales Market Share Forecast by Country (2027-2032) Table 212. Europe Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Europe Semi-Solid Dosage Form Market Size by Country (2021-2026) & (US$ Million) Table 214. Europe Semi-Solid Dosage Form Market Share by Country (2021-2026) Table 215. Europe Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Europe Semi-Solid Dosage Form Market Share Forecast by Country (2027-2032) Table 217. Asia-Pacific Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 218. Asia-Pacific Semi-Solid Dosage Form Sales by Country (2021-2026) & (K Units) Table 219. Asia-Pacific Semi-Solid Dosage Form Sales Market Share by Country (2021-2026) Table 220. Asia-Pacific Semi-Solid Dosage Form Sales Forecast by Country (2027-2032) & (K Units) Table 221. Asia-Pacific Semi-Solid Dosage Form Sales Market Share Forecast by Country (2027-2032) Table 222. Asia-Pacific Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Asia-Pacific Semi-Solid Dosage Form Market Size by Country (2021-2026) & (US$ Million) Table 224. Asia-Pacific Semi-Solid Dosage Form Market Share by Country (2021-2026) Table 225. Asia-Pacific Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Asia-Pacific Semi-Solid Dosage Form Market Share Forecast by Country (2027-2032) Table 227. Latin America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 228. Latin America Semi-Solid Dosage Form Sales by Country (2021-2026) & (K Units) Table 229. Latin America Semi-Solid Dosage Form Sales Market Share by Country (2021-2026) Table 230. Latin America Semi-Solid Dosage Form Sales Forecast by Country (2027-2032) & (K Units) Table 231. Latin America Semi-Solid Dosage Form Sales Market Share Forecast by Country (2027-2032) Table 232. Latin America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Latin America Semi-Solid Dosage Form Market Size by Country (2021-2026) & (US$ Million) Table 234. Latin America Semi-Solid Dosage Form Market Share by Country (2021-2026) Table 235. Latin America Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Latin America Semi-Solid Dosage Form Market Share Forecast by Country (2027-2032) Table 237. Middle East and Africa Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 238. Middle East and Africa Semi-Solid Dosage Form Sales by Country (2021-2026) & (K Units) Table 239. Middle East and Africa Semi-Solid Dosage Form Sales Market Share by Country (2021-2026) Table 240. Middle East and Africa Semi-Solid Dosage Form Sales Forecast by Country (2027-2032) & (K Units) Table 241. Middle East and Africa Semi-Solid Dosage Form Sales Market Share Forecast by Country (2027-2032) Table 242. Middle East and Africa Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 243. Middle East and Africa Semi-Solid Dosage Form Market Size by Country (2021-2026) & (US$ Million) Table 244. Middle East and Africa Semi-Solid Dosage Form Market Share by Country (2021-2026) Table 245. Middle East and Africa Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032) & (US$ Million) Table 246. Middle East and Africa Semi-Solid Dosage Form Market Share Forecast by Country (2027-2032) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. Semi-Solid Dosage Form Distributors List Table 250. Semi-Solid Dosage Form Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. Semi-Solid Dosage Form Image Figure 2. Global Semi-Solid Dosage Form Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Semi-Solid Dosage Form Market Size (2021-2032) & (US$ Million) Figure 4. Global Semi-Solid Dosage Form Sales (2021-2032) & (K Units) Figure 5. Ointments Image Figure 6. Global Ointments Sales YoY Growth (2021-2032) & (K Units) Figure 7. Gels Image Figure 8. Global Gels Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Semi-Solid Dosage Form Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Semi-Solid Dosage Form Market Share by Type 2025 VS 2032 Figure 13. North America Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2025 Figure 14. North America Semi-Solid Dosage Form Sales Market Share in Value by Type in 2025 Figure 15. Europe Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2025 Figure 16. Europe Semi-Solid Dosage Form Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Value by Type in 2025 Figure 19. Latin America Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Semi-Solid Dosage Form Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Semi-Solid Dosage Form Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Nasal Cavity Image Figure 26. Global Nasal Cavity Sales YoY Growth (2021-2032) & (K Units) Figure 27. Skin Image Figure 28. Global Skin Sales YoY Growth (2021-2032) & (K Units) Figure 29. Vaginal Cavity Image Figure 30. Global Vaginal Cavity Sales YoY Growth (2021-2032) & (K Units) Figure 31. Rectal Cavity Image Figure 32. Global Rectal Cavity Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Semi-Solid Dosage Form Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Semi-Solid Dosage Form Market Share by Application 2025 VS 2032 Figure 37. North America Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2025 Figure 38. North America Semi-Solid Dosage Form Sales Market Share in Value by Application in 2025 Figure 39. Europe Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2025 Figure 40. Europe Semi-Solid Dosage Form Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Semi-Solid Dosage Form Sales Market Share in Value by Application in 2025 Figure 43. Latin America Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Semi-Solid Dosage Form Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Semi-Solid Dosage Form Sales Market Share in Value by Application in 2025 Figure 47. North America Semi-Solid Dosage Form Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Semi-Solid Dosage Form Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Semi-Solid Dosage Form Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Semi-Solid Dosage Form Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Semi-Solid Dosage Form Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Semi-Solid Dosage Form Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Semi-Solid Dosage Form Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Semi-Solid Dosage Form Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Semi-Solid Dosage Form Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Semi-Solid Dosage Form Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Semi-Solid Dosage Form Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Semi-Solid Dosage Form Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Semi-Solid Dosage Form Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Semi-Solid Dosage Form Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Semi-Solid Dosage Form Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Semi-Solid Dosage Form Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Semi-Solid Dosage Form Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Semi-Solid Dosage Form Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Semi-Solid Dosage Form Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Semi-Solid Dosage Form Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Semi-Solid Dosage Form Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Semi-Solid Dosage Form Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Gels
  • Others
Applications
  • Nasal Cavity
  • Skin
  • Vaginal Cavity
  • Rectal Cavity
  • Others
Companies covered
  • Aclaris Therapeutics, Inc.
  • Akorn Inc. (US)
  • Allergan plc
  • Almirall, S.A
  • Bausch Health Companies
  • Biofrontera, Inc.
  • Cipla Ltd
  • Crescita Therapeutics Inc.
  • Crown Laboratories Inc.
  • Encore Dermatology, Inc.
  • Glenmark Pharmaceuticals
  • Hisamitsu Pharmaceutical
  • Ingenus Pharmaceuticals
  • LEO Pharma
  • Mylan N.V.
  • Novartis AG
  • Perrigo Pharma
  • Taro Pharmaceutical Industries Ltd.
  • Teligent Pharma
  • Bayer AG
  • GlaxoSmithKline plc
  • Merck & Co
  • Johnson & Johnson
  • Nestlé SA
  • Sun Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Semi-Solid Dosage Form Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Semi-Solid Dosage Form Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Semi-Solid Dosage Form Market by Type
  6. 1.3.1 Ointments
  7. 1.3.2 Gels
  8. 1.3.3 Others
  9. 1.4 Global Semi-Solid Dosage Form Market Size by Type
  10. 1.4.1 Global Semi-Solid Dosage Form Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Semi-Solid Dosage Form Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Semi-Solid Dosage Form Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Semi-Solid Dosage Form Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Semi-Solid Dosage Form Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Semi-Solid Dosage Form Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Semi-Solid Dosage Form Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Semi-Solid Dosage Form Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Semi-Solid Dosage Form Industry Trends
  2. 2.2 Semi-Solid Dosage Form Industry Drivers
  3. 2.3 Semi-Solid Dosage Form Industry Opportunities and Challenges
  4. 2.4 Semi-Solid Dosage Form Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Semi-Solid Dosage Form Revenue (2021-2026)
  2. 3.2 Global Top Players by Semi-Solid Dosage Form Sales (2021-2026)
  3. 3.3 Global Top Players by Semi-Solid Dosage Form Price (2021-2026)
  4. 3.4 Global Semi-Solid Dosage Form Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Semi-Solid Dosage Form Major Company Production Sites & Headquarters
  6. 3.6 Global Semi-Solid Dosage Form Company, Product Type & Application
  7. 3.7 Global Semi-Solid Dosage Form Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Semi-Solid Dosage Form Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Semi-Solid Dosage Form Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Semi-Solid Dosage Form Tier 1, Tier 2, and Tier 3
4 Semi-Solid Dosage Form Regional Status and Outlook
  1. 4.1 Global Semi-Solid Dosage Form Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Semi-Solid Dosage Form Historic Market Size by Region
  3. 4.2.1 Global Semi-Solid Dosage Form Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Semi-Solid Dosage Form Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Semi-Solid Dosage Form Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Semi-Solid Dosage Form Forecasted Market Size by Region
  7. 4.3.1 Global Semi-Solid Dosage Form Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Semi-Solid Dosage Form Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Semi-Solid Dosage Form Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Semi-Solid Dosage Form by Application
  1. 5.1 Semi-Solid Dosage Form Market by Application
  2. 5.1.1 Nasal Cavity
  3. 5.1.2 Skin
  4. 5.1.3 Vaginal Cavity
  5. 5.1.4 Rectal Cavity
  6. 5.1.5 Others
  7. 5.2 Global Semi-Solid Dosage Form Market Size by Application
  8. 5.2.1 Global Semi-Solid Dosage Form Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Semi-Solid Dosage Form Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Semi-Solid Dosage Form Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Semi-Solid Dosage Form Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Semi-Solid Dosage Form Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Semi-Solid Dosage Form Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Semi-Solid Dosage Form Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Semi-Solid Dosage Form Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aclaris Therapeutics, Inc.
  2. 6.1.1 Aclaris Therapeutics, Inc. Company Information
  3. 6.1.2 Aclaris Therapeutics, Inc. Business Overview
  4. 6.1.3 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product Portfolio
  6. 6.1.5 Aclaris Therapeutics, Inc. Recent Developments
  7. 6.2 Akorn Inc. (US)
  8. 6.2.1 Akorn Inc. (US) Company Information
  9. 6.2.2 Akorn Inc. (US) Business Overview
  10. 6.2.3 Akorn Inc. (US) Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Akorn Inc. (US) Semi-Solid Dosage Form Product Portfolio
  12. 6.2.5 Akorn Inc. (US) Recent Developments
  13. 6.3 Allergan plc
  14. 6.3.1 Allergan plc Company Information
  15. 6.3.2 Allergan plc Business Overview
  16. 6.3.3 Allergan plc Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Allergan plc Semi-Solid Dosage Form Product Portfolio
  18. 6.3.5 Allergan plc Recent Developments
  19. 6.4 Almirall, S.A
  20. 6.4.1 Almirall, S.A Company Information
  21. 6.4.2 Almirall, S.A Business Overview
  22. 6.4.3 Almirall, S.A Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Almirall, S.A Semi-Solid Dosage Form Product Portfolio
  24. 6.4.5 Almirall, S.A Recent Developments
  25. 6.5 Bausch Health Companies
  26. 6.5.1 Bausch Health Companies Company Information
  27. 6.5.2 Bausch Health Companies Business Overview
  28. 6.5.3 Bausch Health Companies Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bausch Health Companies Semi-Solid Dosage Form Product Portfolio
  30. 6.5.5 Bausch Health Companies Recent Developments
  31. 6.6 Biofrontera, Inc.
  32. 6.6.1 Biofrontera, Inc. Company Information
  33. 6.6.2 Biofrontera, Inc. Business Overview
  34. 6.6.3 Biofrontera, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Biofrontera, Inc. Semi-Solid Dosage Form Product Portfolio
  36. 6.6.5 Biofrontera, Inc. Recent Developments
  37. 6.7 Cipla Ltd
  38. 6.7.1 Cipla Ltd Company Information
  39. 6.7.2 Cipla Ltd Business Overview
  40. 6.7.3 Cipla Ltd Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cipla Ltd Semi-Solid Dosage Form Product Portfolio
  42. 6.7.5 Cipla Ltd Recent Developments
  43. 6.8 Crescita Therapeutics Inc.
  44. 6.8.1 Crescita Therapeutics Inc. Company Information
  45. 6.8.2 Crescita Therapeutics Inc. Business Overview
  46. 6.8.3 Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Crescita Therapeutics Inc. Semi-Solid Dosage Form Product Portfolio
  48. 6.8.5 Crescita Therapeutics Inc. Recent Developments
  49. 6.9 Crown Laboratories Inc.
  50. 6.9.1 Crown Laboratories Inc. Company Information
  51. 6.9.2 Crown Laboratories Inc. Business Overview
  52. 6.9.3 Crown Laboratories Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Crown Laboratories Inc. Semi-Solid Dosage Form Product Portfolio
  54. 6.9.5 Crown Laboratories Inc. Recent Developments
  55. 6.10 Encore Dermatology, Inc.
  56. 6.10.1 Encore Dermatology, Inc. Company Information
  57. 6.10.2 Encore Dermatology, Inc. Business Overview
  58. 6.10.3 Encore Dermatology, Inc. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Encore Dermatology, Inc. Semi-Solid Dosage Form Product Portfolio
  60. 6.10.5 Encore Dermatology, Inc. Recent Developments
  61. 6.11 Glenmark Pharmaceuticals
  62. 6.11.1 Glenmark Pharmaceuticals Company Information
  63. 6.11.2 Glenmark Pharmaceuticals Business Overview
  64. 6.11.3 Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Glenmark Pharmaceuticals Semi-Solid Dosage Form Product Portfolio
  66. 6.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 6.12 Hisamitsu Pharmaceutical
  68. 6.12.1 Hisamitsu Pharmaceutical Company Information
  69. 6.12.2 Hisamitsu Pharmaceutical Business Overview
  70. 6.12.3 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product Portfolio
  72. 6.12.5 Hisamitsu Pharmaceutical Recent Developments
  73. 6.13 Ingenus Pharmaceuticals
  74. 6.13.1 Ingenus Pharmaceuticals Company Information
  75. 6.13.2 Ingenus Pharmaceuticals Business Overview
  76. 6.13.3 Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ingenus Pharmaceuticals Semi-Solid Dosage Form Product Portfolio
  78. 6.13.5 Ingenus Pharmaceuticals Recent Developments
  79. 6.14 LEO Pharma
  80. 6.14.1 LEO Pharma Company Information
  81. 6.14.2 LEO Pharma Business Overview
  82. 6.14.3 LEO Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 LEO Pharma Semi-Solid Dosage Form Product Portfolio
  84. 6.14.5 LEO Pharma Recent Developments
  85. 6.15 Mylan N.V.
  86. 6.15.1 Mylan N.V. Company Information
  87. 6.15.2 Mylan N.V. Business Overview
  88. 6.15.3 Mylan N.V. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Mylan N.V. Semi-Solid Dosage Form Product Portfolio
  90. 6.15.5 Mylan N.V. Recent Developments
  91. 6.16 Novartis AG
  92. 6.16.1 Novartis AG Company Information
  93. 6.16.2 Novartis AG Business Overview
  94. 6.16.3 Novartis AG Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Novartis AG Semi-Solid Dosage Form Product Portfolio
  96. 6.16.5 Novartis AG Recent Developments
  97. 6.17 Perrigo Pharma
  98. 6.17.1 Perrigo Pharma Company Information
  99. 6.17.2 Perrigo Pharma Business Overview
  100. 6.17.3 Perrigo Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Perrigo Pharma Semi-Solid Dosage Form Product Portfolio
  102. 6.17.5 Perrigo Pharma Recent Developments
  103. 6.18 Taro Pharmaceutical Industries Ltd.
  104. 6.18.1 Taro Pharmaceutical Industries Ltd. Company Information
  105. 6.18.2 Taro Pharmaceutical Industries Ltd. Business Overview
  106. 6.18.3 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product Portfolio
  108. 6.18.5 Taro Pharmaceutical Industries Ltd. Recent Developments
  109. 6.19 Teligent Pharma
  110. 6.19.1 Teligent Pharma Company Information
  111. 6.19.2 Teligent Pharma Business Overview
  112. 6.19.3 Teligent Pharma Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Teligent Pharma Semi-Solid Dosage Form Product Portfolio
  114. 6.19.5 Teligent Pharma Recent Developments
  115. 6.20 Bayer AG
  116. 6.20.1 Bayer AG Company Information
  117. 6.20.2 Bayer AG Business Overview
  118. 6.20.3 Bayer AG Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Bayer AG Semi-Solid Dosage Form Product Portfolio
  120. 6.20.5 Bayer AG Recent Developments
  121. 6.21 GlaxoSmithKline plc
  122. 6.21.1 GlaxoSmithKline plc Company Information
  123. 6.21.2 GlaxoSmithKline plc Business Overview
  124. 6.21.3 GlaxoSmithKline plc Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 GlaxoSmithKline plc Semi-Solid Dosage Form Product Portfolio
  126. 6.21.5 GlaxoSmithKline plc Recent Developments
  127. 6.22 Merck & Co
  128. 6.22.1 Merck & Co Company Information
  129. 6.22.2 Merck & Co Business Overview
  130. 6.22.3 Merck & Co Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Merck & Co Semi-Solid Dosage Form Product Portfolio
  132. 6.22.5 Merck & Co Recent Developments
  133. 6.23 Johnson & Johnson
  134. 6.23.1 Johnson & Johnson Company Information
  135. 6.23.2 Johnson & Johnson Business Overview
  136. 6.23.3 Johnson & Johnson Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Johnson & Johnson Semi-Solid Dosage Form Product Portfolio
  138. 6.23.5 Johnson & Johnson Recent Developments
  139. 6.24 Nestlé SA
  140. 6.24.1 Nestlé SA Company Information
  141. 6.24.2 Nestlé SA Business Overview
  142. 6.24.3 Nestlé SA Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Nestlé SA Semi-Solid Dosage Form Product Portfolio
  144. 6.24.5 Nestlé SA Recent Developments
  145. 6.25 Sun Pharmaceuticals
  146. 6.25.1 Sun Pharmaceuticals Company Information
  147. 6.25.2 Sun Pharmaceuticals Business Overview
  148. 6.25.3 Sun Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Sun Pharmaceuticals Semi-Solid Dosage Form Product Portfolio
  150. 6.25.5 Sun Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Semi-Solid Dosage Form Sales by Country
  2. 7.1.1 North America Semi-Solid Dosage Form Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Semi-Solid Dosage Form Sales by Country (2021-2026)
  4. 7.1.3 North America Semi-Solid Dosage Form Sales Forecast by Country (2027-2032)
  5. 7.2 North America Semi-Solid Dosage Form Market Size by Country
  6. 7.2.1 North America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Semi-Solid Dosage Form Market Size by Country (2021-2026)
  8. 7.2.3 North America Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Semi-Solid Dosage Form Sales by Country
  2. 8.1.1 Europe Semi-Solid Dosage Form Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Semi-Solid Dosage Form Sales by Country (2021-2026)
  4. 8.1.3 Europe Semi-Solid Dosage Form Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Semi-Solid Dosage Form Market Size by Country
  6. 8.2.1 Europe Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Semi-Solid Dosage Form Market Size by Country (2021-2026)
  8. 8.2.3 Europe Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Semi-Solid Dosage Form Sales by Country
  2. 9.1.1 Asia-Pacific Semi-Solid Dosage Form Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Semi-Solid Dosage Form Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Semi-Solid Dosage Form Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Semi-Solid Dosage Form Market Size by Country
  6. 9.2.1 Asia-Pacific Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Semi-Solid Dosage Form Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Semi-Solid Dosage Form Sales by Country
  2. 10.1.1 South America Semi-Solid Dosage Form Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Semi-Solid Dosage Form Sales by Country (2021-2026)
  4. 10.1.3 South America Semi-Solid Dosage Form Sales Forecast by Country (2027-2032)
  5. 10.2 South America Semi-Solid Dosage Form Market Size by Country
  6. 10.2.1 South America Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Semi-Solid Dosage Form Market Size by Country (2021-2026)
  8. 10.2.3 South America Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Semi-Solid Dosage Form Sales by Country
  2. 11.1.1 Middle East and Africa Semi-Solid Dosage Form Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Semi-Solid Dosage Form Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Semi-Solid Dosage Form Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Semi-Solid Dosage Form Market Size by Country
  6. 11.2.1 Middle East and Africa Semi-Solid Dosage Form Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Semi-Solid Dosage Form Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Semi-Solid Dosage Form Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Semi-Solid Dosage Form Value Chain Analysis
  2. 12.1.1 Semi-Solid Dosage Form Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Semi-Solid Dosage Form Production Mode & Process
  7. 12.2 Semi-Solid Dosage Form Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Semi-Solid Dosage Form Distributors
  10. 12.2.3 Semi-Solid Dosage Form Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst